10.2337/diabetes.47.11.1663 10
Overall, no causal link has ever been established between MT-II and cancer and importantly, the homologous synthetic peptide, MT-1, is FDA-approved and operates via the same mechanism of action with respect to activation of melanocortin receptors in melanocytes [7]
That's our specialty
GLP-1 Injections Offered Or Discussed At Soboba Weight Loss Soboba Weight Loss helps patients explore medical weight-loss options, including GLP-1 and related medications
TB-500 is based on a part of TB4, so it should, in theory, have a similar safety profile, but studies specifically analyzing its safety still need to be conducted
doi: 10.3389/fendo.2022.810242 Received 06 November 2021 Accepted 24 January 2022 Published 21 February 2022 Volume 13 - 2022 Edited by Davor Jezek, University of Zagreb, Croatia Reviewed by Gian Maria Busetto, University of Foggia, Italy